We are live on ! Find out more
ACM

Ardent Capital Management Portfolio holdings

AUM $241M
1-Year Est. Return 23.63%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+23.63%
3 Year Est. Return
+77.52%
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$10.3M
Cap. Flow
+$2.49M
Cap. Flow %
1.79%
Top 10 Hldgs %
90.59%
Holding
30
New
3
Increased
9
Reduced
10
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 39.95%
2 Healthcare 22.79%
3 Technology 17.13%
4 Communication Services 10.81%
5 Consumer Staples 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.1T
$43.9M 31.55%
142,178
+846
+0.6% +$261K
AAPL icon
2
Apple
AAPL
$4.54T
$23.5M 16.92%
142,772
-854
-0.6% -$126K
JNJ icon
3
Johnson & Johnson
JNJ
$618B
$20.8M 14.93%
134,036
+2,709
+2% +$437K
JPM icon
4
JPMorgan Chase
JPM
$935B
$10.3M 7.37%
78,732
-338
-0.4% -$46.3K
SYK icon
5
Stryker
SYK
$125B
$7.35M 5.28%
25,742
+1,045
+4% +$277K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.36T
$6.37M 4.58%
61,209
+929
+2% +$89.7K
META icon
7
Meta Platforms (Facebook)
META
$1.42T
$6.02M 4.33%
28,405
+19
+0.1% +$3.24K
PG icon
8
Procter & Gamble
PG
$336B
$3.18M 2.28%
21,381
-29
-0.1% -$4.15K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.36T
$2.65M 1.9%
25,540
-181
-0.7% -$17.4K
PM icon
10
Philip Morris
PM
$297B
$2.01M 1.45%
20,678
+38
+0.2% +$3.79K
COST icon
11
Costco
COST
$422B
$1.93M 1.38%
3,875
+14
+0.4% +$6.87K
JNCE
12
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.71M 1.23%
+923,463
New +$1.14M
ZBH icon
13
Zimmer Biomet
ZBH
$18.2B
$1.46M 1.05%
11,314
-47
-0.4% -$5.9K
CRWS icon
14
Crown Crafts
CRWS
$31.7M
$1.38M 0.99%
239,064
-7,744
-3% -$44.1K
PYPL icon
15
PayPal
PYPL
$48.9B
$906K 0.65%
+11,928
New +$919K
AMZN icon
16
Amazon
AMZN
$2.92T
$903K 0.65%
8,740
-120
-1% -$11.6K
IVV icon
17
iShares Core S&P 500 ETF
IVV
$872B
$808K 0.58%
1,966
PLD icon
18
Prologis
PLD
$135B
$577K 0.41%
4,627
+637
+16% +$78.3K
SPY icon
19
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$537K 0.39%
1,311
ABBV icon
20
AbbVie
ABBV
$443B
$412K 0.3%
2,585
MDY icon
21
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$358K 0.26%
780
-150
-16% -$69.9K
IWF icon
22
iShares Russell 1000 Growth ETF
IWF
$121B
$303K 0.22%
4,964
MSFT icon
23
Microsoft
MSFT
$3.45T
$298K 0.21%
1,035
FITB
24
Fifth Third Bancorp
FITB
$51.2B
$293K 0.21%
11,000
IWB icon
25
iShares Russell 1000 ETF
IWB
$48.3B
$286K 0.21%
1,269
-324
-20% -$71.3K

Similar funds

Ardent Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Ardent Capital Management held 30 positions worth $139M, up 8% from $129M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Ardent Capital Management's Q1 2023 filing shows 3 new, 9 increased, 10 reduced and 1 closed positions. Its largest new stake was Jounce Therapeutics, Inc. Common Stock: 923,463 shares worth $1.71M. The largest sale was Bristol-Myers Squibb, an estimated $529K.

By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 43% a quarter earlier, followed by Healthcare and Technology.

  • Ardent Capital Management's largest Q1 2023 buy was Jounce Therapeutics, Inc. Common Stock: 923,463 shares worth $1.71M.
  • Ardent Capital Management added most to Johnson & Johnson in Q1 2023, an estimated $437K increase.
  • Ardent Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $126K.
  • Ardent Capital Management fully exited Bristol-Myers Squibb in Q1 2023, selling an estimated $529K.
  • Ardent Capital Management's ten largest holdings make up 91% of its $139M portfolio in Q1 2023.
  • Ardent Capital Management opened 3 new positions and closed 1 in Q1 2023.
  • Ardent Capital Management's portfolio value rose 8% quarter-over-quarter to $139M.

Based on Ardent Capital Management's 13F filing for Q1 2023, filed 12 May 2023.